ROBERT SALAZAR: Open Payments
NPI 1104841253 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,956 in 43 payments from 7 companies in 2025. Trend: 2023 $4,476 · 2024 $1,031 · 2025 $3,956
Speaker / faculty: $2,500Food & beverage: $1,456
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 33 | $3,711 |
| Boston Scientific Corporation | 3 | $96 |
| Forte Bio-Pharma LLC | 2 | $40 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Abbott Laboratories | 1 | $22 |
| Curonix LLC | 1 | $17 |
Products named: INTELLIS ADAPTIVESTIM, INCEPTIV, SYNCHROMEDII, General - Pain Management, PROLATE, JOURNAVX, Intracept, Sunosi.
Industry payments across CA — which companies pay providers there.
